0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Other Articles |

RHEUMATIC PERICARDITIS WITH EFFUSION TREATED WITH SALICYLATES

ERNST P. BOAS, M.D.; MAX ELLENBERG, M.D.
JAMA. 1940;115(5):345-348. doi:10.1001/jama.1940.02810310003002.
Text Size: A A A
Published online

Salicylates have been used in the treatment of acute articular rheumatism for some sixty years, but there remain wide differences of opinion with regard to their usefulness and mode of action. Yet the use of the drug persists, and studies of its clinical applications are still being published. In the United States, clinical practice largely restricts the use of salicylates to the relief of acute rheumatic arthritis. In Europe, particularly in France, the salicylates are regarded as valuable measures in the treatment of the cardiac manifestations of rheumatic fever.

A number of careful studies made in this country beginning with one by Miller1 in 1914 and continuing to that of Master and Romanoff2 in 1932 show that the administration of salicylates does not reduce the frequency of cardiac complications of patients with rheumatic fever. Wyckoff, DeGraff and Parent3 demonstrated by electrocardiographic studies that the conduction disturbances which

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();